HomeNSB • ASX
add
Neuroscientific Biopharmaceuticals Ltd
Previous close
$0.10
Day range
$0.10 - $0.13
Year range
$0.033 - $0.26
Market cap
38.25M AUD
Avg Volume
294.58K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 774.66K | 114.38% |
Net income | -738.98K | -195.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -750.80K | -199.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.27M | 46.66% |
Total assets | 16.96M | 212.05% |
Total liabilities | 149.22K | 74.16% |
Total equity | 16.81M | — |
Shares outstanding | 332.58M | — |
Price to book | 2.00 | — |
Return on assets | -11.41% | — |
Return on capital | -11.51% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -738.98K | -195.08% |
Cash from operations | -240.27K | -129.71% |
Cash from investing | -18.02K | — |
Cash from financing | 1.64M | — |
Net change in cash | 1.39M | 71.38% |
Free cash flow | -61.40K | -112.37% |
About
Founded
2002
Website
